Intercept Pharmaceuticals Inc Capitalización de mercado
¿Qué es el Capitalización de mercado de Intercept Pharmaceuticals Inc?
El Capitalización de mercado de Intercept Pharmaceuticals Inc es $460.93M
¿Cuál es la definición de Capitalización de mercado ?
La capitalización de mercado es el valor de mercado en un momento en el tiempo de las acciones en circulación de una empresa que cotiza en bolsa, que es igual al precio de la acción en ese punto de tiempo por el número de acciones en circulación .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalización de mercado de compañías en Sector Health Care en NASDAQ en comparadas con Intercept Pharmaceuticals Inc
¿Qué hace Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas con capitalización de mercado similar a Intercept Pharmaceuticals Inc
- Carter Bank & Trust tiene Capitalización de mercado de $459.11M
- Custom Truck One Source Inc tiene Capitalización de mercado de $459.62M
- Gateway Distriparks tiene Capitalización de mercado de $460.03M
- Similarweb tiene Capitalización de mercado de $460.69M
- I.T tiene Capitalización de mercado de $460.69M
- PM Capital Global Opportunities Fund tiene Capitalización de mercado de $460.80M
- Intercept Pharmaceuticals Inc tiene Capitalización de mercado de $460.93M
- Pierre & Vacances SA tiene Capitalización de mercado de $461.00M
- Smith & Wesson Brands tiene Capitalización de mercado de $461.24M
- Cardinal Resources tiene Capitalización de mercado de $461.84M
- Invesco Mortgage Capital Inc tiene Capitalización de mercado de $461.86M
- Greatland Gold Plc tiene Capitalización de mercado de $461.87M
- Misonix Inc tiene Capitalización de mercado de $461.98M